Clinical Trial

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 68Ga/18F-Pentixafor/Pentixather positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various CXCR4-related disease patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-13.
Trial Details
NCT Number NCT06690736
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions CXCR4-related Disease, Tumor, Positron Emission Tomography, Metastasis
Enrollment 200 participants
Start Date 2022-03-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-11